0001213900-25-117804.txt : 20251203 0001213900-25-117804.hdr.sgml : 20251203 20251203160112 ACCESSION NUMBER: 0001213900-25-117804 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20251203 DATE AS OF CHANGE: 20251203 EFFECTIVENESS DATE: 20251203 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ADIAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001513525 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 800667150 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-565667 FILM NUMBER: 251546381 BUSINESS ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 BUSINESS PHONE: 434-422-9800 MAIL ADDRESS: STREET 1: 1180 SEMINOLE TRAIL STREET 2: SUITE 495 CITY: CHARLOTTESVILLE STATE: VA ZIP: 22901 FORMER COMPANY: FORMER CONFORMED NAME: ADial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20170515 FORMER COMPANY: FORMER CONFORMED NAME: Adial Pharmaceuticals, L.L.C. DATE OF NAME CHANGE: 20110218 D 1 primary_doc.xml X0708 D LIVE 0001513525 ADIAL PHARMACEUTICALS, INC. 4870 SADLER ROAD SUITE 300 GLEN ALLEN VA VIRGINIA 23060 (804) 487-8196 DELAWARE Adial Pharmaceuticals L.L.C. ADial Pharmaceuticals, L.L.C. Adial Pharmaceuticals, L.L.C. Corporation true Cary J. Claiborne 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer Director Chief Executive Officer Vinay Shah 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer Chief Financial Officer James K. Anderson 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director Robertson H. Gilliland 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director James W. Newman, Jr. 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director Kevin W. Schuyler, CFA 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Director Tony Goodman 4870 Sadler Road Suite 300 Glen Allen VA VIRGINIA 23060 Executive Officer Director Chief Operating Officer Pharmaceuticals Decline to Disclose 06b false 2025-11-28 false true true false 0 A.G.P./Alliance Global Partners 000005361 None None 590 Madison Avenue 28th Floor New York NY NEW YORK 10022 NY NEW YORK false 4285289 4285289 0 Consists of $0.31 per share that may be received upon future exercise of warrants to purchase up to 13,823,512 shares of common stock. false 1 228549 true 0 0 true false ADIAL PHARMACEUTICALS, INC. /s/ Cary J. Claiborne Cary J. Claiborne Chief Executive Officer 2025-12-03